In vitro studies on the action of CS-045, a new antidiabetic agent.

[1]  J. Olefsky,et al.  Long-term regulation of adipocyte glucose transport capacity by circulating insulin in rats. , 1978, The Journal of clinical investigation.

[2]  L. Orci,et al.  Insulin receptors and bioresponses in a human liver cell line (Hep G-2). , 1985, European journal of biochemistry.

[3]  Gerich Je,et al.  Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues , 1978 .

[4]  J. Olefsky,et al.  Insulin Induces Progressive Insulin Resistance in Cultured Rat Adipocytes: Sequential Effects at Receptor and Multiple Postreceptor Sites , 1986, Diabetes.

[5]  I. Goldfine,et al.  Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. , 1987, The Journal of biological chemistry.

[6]  L. Glaser,et al.  Multiple Controls for the Synthesis of Muscle-specific Proteins in Bc3h1 Cells Materials and Methods , 1982 .

[7]  I. Goldfine,et al.  Insulin and insulin-like growth factor I regulate the same biological functions in HEP-G2 cells via their own specific receptors. , 1988, The Journal of clinical endocrinology and metabolism.

[8]  J. Olefsky,et al.  The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes. , 1984, Diabetes care.

[9]  F. Capani,et al.  Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM , 1989, Diabetes.

[10]  M. Standaert,et al.  The development of insulin receptors and responses in the differentiating nonfusing muscle cell line BC3H-1. , 1984, The Journal of biological chemistry.

[11]  T. B. Miller,et al.  Regulation of glycogen metabolism in primary cultures of rat hepatocytes. Restoration of acute effects of insulin and glucose in cells from diabetic rats. , 1986, The Journal of biological chemistry.

[12]  E. Krebs,et al.  Phosphorylation-dephosphorylation of enzymes. , 1979, Annual review of biochemistry.

[13]  H. Lebovitz,et al.  Sulphonylureas increase the number of insulin receptors , 1978, Nature.

[14]  P. Arner,et al.  Reversal of insulin resistance in adipose tissue of non-insulin-dependent diabetics by treatment with diet and sulphonylurea. , 1985, Acta endocrinologica.

[15]  W. Fleig,et al.  Modulation by a Sulfonylurea of Insulin-dependent Glycogenesis, but Not of Insulin Binding, in Cultured Rat Hepatocytes: Evidence for a Postreceptor Mechanism of Action , 1984, Diabetes.

[16]  K. Jungermann,et al.  Induction in primary culture of 'gluconeogenic' and 'glycolytic' hepatocytes resembling periportal and perivenous cells. , 2005, European journal of biochemistry.

[17]  S. Solomon,et al.  Cyclic AMP Phosphodiesterase in Diabetes: Effect of Glyburide , 1986, Diabetes.

[18]  J. Amatruda,et al.  Potentiation of Insulin Action by a Sulfonylurea in Primary Cultures of Hepatocytes from Normal and Diabetic Rats , 1983, Diabetes.

[19]  J. Olefsky,et al.  Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors. , 1980, The Journal of clinical investigation.

[20]  T. Sturgill,et al.  Insulin-stimulated microtubule associated protein kinase is detectable by analytical gel chromatography as a 35-kDa protein in myocytes, adipocytes, and hepatocytes. , 1988, Archives of biochemistry and biophysics.

[21]  M. Davidson,et al.  Effect of glyburide on glycogen metabolism in cultured rat hepatocytes. , 1987, Metabolism: clinical and experimental.

[22]  R. Vigneri,et al.  Effects of biguanides and sulfonylureas on insulin receptors in cultured cells. , 1984, Diabetes Care.

[23]  J. Olefsky,et al.  Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. , 1985, The American journal of medicine.

[24]  A. Brunetti,et al.  Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels. , 1989, The Journal of clinical investigation.

[25]  G. Reaven,et al.  Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus , 1967, Diabetes.

[26]  A. Soutar,et al.  Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma Hep G2 cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL. , 1988, European journal of biochemistry.

[27]  E. Cerasi,et al.  In Vitro Autoregulation of Glucose Utilization in Rat Soleus Muscle , 1987, Diabetes.

[28]  S. Heinemann,et al.  CHARACTERIZATION OF A UNIQUE MUSCLE CELL LINE , 1974, The Journal of cell biology.

[29]  J. Gavin.  Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects. , 1985, The American journal of medicine.

[30]  G. Ward,et al.  Gliclazide Therapy Is Associated with Potentiation of Postbinding Insulin Action in Obese, Non-insulin-dependent Diabetic Subjects , 1985, Diabetes.

[31]  J. Poulos,et al.  Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. , 1988, The Journal of clinical investigation.

[32]  R. Farese,et al.  Insulin increases membrane and cytosolic protein kinase C activity in BC3H-1 myocytes. , 1987, The Journal of biological chemistry.

[33]  H. Beck-Nielsen,et al.  Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus. , 1984, Diabetes care.

[34]  G. Bray,et al.  Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects. , 1986, Metabolism: clinical and experimental.

[35]  L. Agius,et al.  Epidermal growth factor counteracts the glycogenic effect of insulin in parenchymal hepatocyte cultures. , 1987, Biochemical Journal.

[36]  J. A. Thomas,et al.  A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. , 1968, Analytical biochemistry.

[37]  I. Goldfine,et al.  Biosynthesis and Processing of the Human Insulin Receptor , 1986, Diabetes.

[38]  R. Jones,et al.  Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide. , 1981, The Journal of clinical investigation.

[39]  N. Wollen,et al.  Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin. , 1988, Biochemical pharmacology.

[40]  C. Jung,et al.  Sulfonylurea potentiates insulin-induced recruitment of glucose transport carrier in rat adipocytes. , 1985, The Journal of biological chemistry.

[41]  J. Larner,et al.  Insulin-like and Insulin-enhancing Effects of the Sulfonylurea Glyburide on Rat Adipose Glycogen Synthase , 1985, Diabetes.

[42]  T. Fujiwara,et al.  Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and ob/ob Mice and Zucker Fatty Rats , 1988, Diabetes.

[43]  F. Nuttall,et al.  Regulation of glycogen synthesis in the liver. , 1988, The American journal of medicine.

[44]  J. Olefsky.  Pathogenesis of Insulin Resistance and Hyperglycemia in Non-Insulin-Dependent Diabetes Mellitus , 1985 .

[45]  J. A. Scarlett,et al.  The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects , 1984, Diabetes.